We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Repurposed Drug Could Open Door to More Stem Cell Transplants

News   Dec 21, 2017 | Original story from University of British Columbia

 
Repurposed Drug Could Open Door to More Stem Cell Transplants

This is Peter Zandstra, director of UBC's School of Biomedical Engineering and Michael Smith Laboratories, and chief scientific officer of the Centre for Commercialization of Regenerative Medicine. Credit: UBC/Paul Joseph

 
 
 

RELATED ARTICLES

Drugs to Prevent Stroke and Dementia Show Promise in Early Trial

News

Treatments that prevent recurrence of types of stroke and dementia caused by damage to small blood vessels in the brain have moved a step closer, following a small study.

READ MORE

Unlocking the Ancient Secrets of Medicinal Mint

News

The precious chemistry of a plant used for 2000 years in traditional Chinese medicine has been unlocked in a project that raises the prospect of rapid access to a wide array of therapeutic drugs.

READ MORE

Targeted Therapy Proves Effective Against Aggressive Blood Cancer in Clinical Trial

News

A multi-institutional clinical trial has given good results for a targeted therapy to treat a rare, aggressive blood cancer known as blastic plasmacytoid dendritic-cell neoplasm (BPDCN).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE